Product Code: BIO099G
The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.
The North American market for single-use technologies for biopharmaceuticals was valued at $2.9 billion in 2025 and, is estimated to reach $3.2 billion by 2026 and $5.6 billion by 2031, at a CAGR of 12% from 2026 through 2031.
The Asia-Pacific market for single-use technologies for biopharmaceuticals was valued at $2.2 billion in 2025 and, is estimated to reach $2.5 billion by 2026 and $4.7 billion by 2031, at a CAGR of 13.4% from 2026 through 2031.
Report Scope
The report provides an overview of the global single-use technologies market and analyzes market trends. The report includes global revenue ($ Million) for the base year data (2025) and estimated data for the forecast period (2026 through 2031). The market is segmented by technology type, product type, component type, assembly model, usage, end user, and application. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World, with a focus on major countries in each region.
The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, including rankings of key participants in the global single-use technologies market and patent landscape. It also features a dedicated section of company profiles that covers details such as overview, key financials, product portfolio, and recent developments of key market participants.
Report Includes
- 110 data tables and 53 additional tables
- Analysis of the global single-use technologies for biopharmaceuticals market, including current market size and future growth potential
- Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
- Detailed segmentation of the market by technology, component, application and region
- Analysis of key market drivers, restraints, and opportunities influencing market growth
- Insights into industry trends, emerging technologies, and developments in single-use technologies for biopharmaceuticals
- Evaluation of the regulatory landscape across major regions
- Analysis of regional markets, including North America, Europe, Asia-Pacific and Rest of the World
- Competitive landscape analysis, including market share, ranking, and strategic developments of key players
- Company profiles of major players within the industry, including Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Historical Analysis: The Foundation for Single-Use Technology
- Raw Materials Used in Single-Use Technologies
- Polyamide
- Polycarbonate
- Polyethylene
- Polyethersulfone
- Polypropylene
- Polytetrafluoroethylene
- Polyvinyl Chloride
- Cellulose Acetate
- Ethylene Vinyl Acetate
- Single-Use Technology Versus Traditional Reusable Technology
- Macro-Economic Factors Analysis
- PESTEL Analysis
- Porter's Five Forces Analysis
- Potential for New Entrants (Moderate)
- Bargaining Power of Suppliers (Moderate)
- Bargaining Power of Buyers (Moderate)
- Threat of Substitutes (Moderate)
- Competition in the Industry (High)
- Impact of U.S.-Israel-Iran War
Chapter 3 Market Dynamics
- Market Drivers
- Growing Demand for Biologics
- Technological Advances in SUTs
- Increasing Number of Contract Manufacturing Organizations (CMOs)
- Market Restraints
- Complex Regulations and Validation Requirements
- Disposal of Plastic Waste
- Integration Challenges
- Market Opportunities
- Rising Demand for Cell and Gene Therapy
- Growth in Emerging Markets
- Expansion of Customized Single-Use Assemblies
Chapter 4 Regulatory Landscape
- FDA Regulations
- EMA Regulations
- APAC Regulations
Chapter 5 Emerging Technologies and Developments
- Introduction
- Miniaturization of Bioreactors
- Continuous Bioprocessing
- Integration of Artificial Intelligence
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown by Technology
- Key Takeaways
- Single-Use Bioreactors
- Mixing, Storage, and Filling Systems
- Filtration Systems
- Control Systems
- Freeze and Thaw Systems
- Chromatography Systems
- Centrifugal Pumps
- Isolators
- Market Breakdown by Component
- Key Takeaways
- Bioprocess Containers
- Filter Cartridges
- Single-Use Sensors
- Media Bags
- Sampling Systems
- Tubing
- Transfer Systems
- Connectors
- Other Single-Use Components
- Market Breakdown by Assembly Model
- Key Takeaways
- Vendor Assembly Model
- Free Component Model
- Market Breakdown by Usage
- Key Takeaways
- Market Breakdown by Application
- Key Takeaways
- Monoclonal Antibodies
- Vaccines
- Stem Cell and Other Cell Therapies
- Blood Derivatives
- Gene Therapy
- Recombinant Proteins
- Polyclonal Antibodies
- Market Breakdown by End User
- Key Takeaways
- Biopharmaceutical Companies and Contract Manufacturers
- Research Institutes and Academia
- Pathology Laboratories
- Geographic Breakdown
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Competitive Intelligence
- Key Takeaways
- Strategic Analysis
- Agreement, Collaboration, and Partnership
- Product Launch
- Expansion
- Acquistion and Other Strategies
Chapter 8 Patent Landscape
Chapter 9 Appendix
- Methodology
- Abbreviations
- References
- Company Profiles
- ABER INSTRUMENTS LTD.
- ADOLF KUHNER AG
- CELLEXUS
- CELLTAINER
- CORNING INC.
- CYTIVA
- DISTEK INC.
- EPPENDORF SE
- GETINGE
- LONZA
- MERCK KGaA
- REPLIGEN CORP.
- SARTORIUS AG
- THERMO FISHER SCIENTIFIC INC.